Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation

被引:441
|
作者
Lemere, CA
Blusztajn, JK
Yamaguchi, H
Wisniewski, T
Saido, TC
Selkoe, DJ
机构
[1] HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,BOSTON,MA 02115
[2] BOSTON UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02215
[3] GUNMA UNIV,COLL MED CARE & TECHNOL,GUNMA,JAPAN
[4] NYU,MED CTR,DEPT NEUROL,NEW YORK,NY 10012
[5] TOKYO METROPOLITAN INST MED SCI,DEPT MOL BIOL,TOKYO 113,JAPAN
关键词
D O I
10.1006/nbdi.1996.0003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Patients with trisomy 21 [Down syndrome (DS)] progressively develop amyloid beta-protein (A beta) deposits and then other features of Alzheimer's disease (AD), apparently due to increased gene dosage and thus expression of the beta-amyloid precursor protein, Because the neuropathological phenotype in older DS subjects closely resembles that of AD, the examination of DS brains of increasing age provides a unique model of the progression of AD. Here, we characterized the deposition of several A beta peptides and apolipoprotein E in formalin-fixed brain sections from 29 DS subjects between 3 and 73 years old, Amyloid plaque number and the percentage of cortical area they occupied were quantified by computerized image analysis. A beta ending at amino acid 42 (A beta(42)) was the earliest form of A beta deposited in DS cortex, It was observed in 7 of 16 young (3-30 years) subjects, with the earliest deposition occurring at age 12. A beta ending at residue 40 (A beta(40)) was not detected until similar to age 30, a time when degenerating neurites around A beta immunoreactive (IR) plaques were first observed, and the frequency of A beta(40) IR plaques then rose with age, Even in old (51-73 years) DS subjects, A beta(42) IR plaques were always more abundant than A beta(40) IR plaques, A beta peptides starting at aspartate 1 or pyroglutamate 3 were detected in small subsets of compacted, neuritic plaques beginning around age 30 and rose with age, the latter species always exceeding the former, Thus, the N-termini of the A beta(42) peptides abundantly deposited in very young DS subjects remain unknown, Apo E was detectable in a small subset of A beta(42) in plaques beginning at age 12 and rose steadily with age; it clearly followed the deposition of A beta. Our analysis of very young DS brains suggests that amyloid plaque formation begins with A beta(42)-ending peptides, and the number and percentage of cortical area of A beta(42) plaques increase very little with advancing age, while other heterogeneous A beta species and Apo E progressively accrue onto plaques containing A beta(42). (C) 1996 Academic Press, Inc.
引用
收藏
页码:16 / 32
页数:17
相关论文
共 21 条
  • [1] Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome
    Teller, JK
    Russo, C
    DeBusk, LM
    Angelini, G
    Zaccheo, D
    DagnaBricarelli, F
    Scartezzini, P
    Bertolini, S
    Mann, DMA
    Tabaton, M
    Gambetti, P
    NATURE MEDICINE, 1996, 2 (01) : 93 - 95
  • [2] Down syndrome and beta-amyloid deposition
    Head, E
    Lott, IT
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (02) : 95 - 100
  • [3] EVIDENCE FOR A DIFFUSIONAL MODEL OF ALZHEIMER AMYLOID A4 (BETA-AMYLOID) DEPOSITION DURING NEURITIC PLAQUE-FORMATION
    BENES, FM
    REIFEL, JL
    MAJOCHA, RE
    MAROTTA, CA
    NEUROSCIENCE, 1989, 33 (03) : 483 - 488
  • [4] Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation
    Lambermon, MHL
    Rappaport, RV
    McLaurin, J
    JOURNAL OF NEUROCHEMISTRY, 2005, 95 (06) : 1667 - 1676
  • [5] GRAY MATTER VOLUME ASSOCIATIONS WITH AMYLOID-BETA DEPOSITION AND AGE IN DOWN SYNDROME
    Lao, P. J.
    Betthauser, T. J.
    Hillmer, A. T.
    Tudarascu, D. L.
    Price, J. C.
    Klunk, W. E.
    Mihaila, I.
    Higgins, A. T.
    Bulova, P. D.
    Hartley, S. L.
    Tumuluru, R. V.
    Murali, D.
    Mathis, C. A.
    Cohen, A. D.
    Barnhart, T. E.
    Devenny, D. A.
    Mailick, M. R.
    Johnson, S. C.
    Handen, B. L.
    Christian, B. T.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 : 108 - 109
  • [6] Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline
    Cole, James H.
    Annus, Tiina
    Wilson, Liam R.
    Remtulla, Ridhaa
    Hong, Young T.
    Fryer, Tim D.
    Acosta-Cabronero, Julio
    Cardenas-Blanco, Arturo
    Smith, Robert
    Menon, David K.
    Zaman, Shahid H.
    Nestor, Peter J.
    Holland, Anthony J.
    NEUROBIOLOGY OF AGING, 2017, 56 : 41 - 49
  • [7] CONVERGENT SOLID-PHASE APPROACH PERFORMED IN A CHLOROFORM-PHENOL MIXED SOLVENT: SYNTHESIS OF AMYLOID BETA-PEPTIDES AS EXAMPLES WITH A DIFFICULT SEQUENCE
    Nishiuchi, Y.
    Nishio, H.
    Ishimaru, M.
    Kimura, T.
    JOURNAL OF PEPTIDE SCIENCE, 2004, 10 : 132 - 132
  • [8] Plasma amyloid beta protein (A beta) in Down's syndrome (DS): Implications for Alzheimer's disease (AD)
    GraffRadford, NR
    Eckman, CB
    OBrien, PC
    Younkin, SG
    NEUROLOGY, 1997, 48 (03) : 63005 - 63005
  • [9] Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer’s disease pathology in Down syndrome
    Alison M. Maxwell
    Peng Yuan
    Brianna M. Rivera
    Wilder Schaaf
    Mihovil Mladinov
    Vee P. Prasher
    Andrew C. Robinson
    William F. DeGrado
    Carlo Condello
    Acta Neuropathologica Communications, 9
  • [10] Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer's disease pathology in Down syndrome
    Maxwell, Alison M.
    Yuan, Peng
    Rivera, Brianna M.
    Schaaf, Wilder
    Mladinov, Mihovil
    Prasher, Vee P.
    Robinson, Andrew C.
    DeGrado, William F.
    Condello, Carlo
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)